Meet Dr. Ravitskiy

Dr. Ravitskiy is an American Board of Dermatology certified physician with clinical expertise in Mohs micrographic surgery and cutaneous oncology. She is also interested in managing skin cancers in transplant and other immunosuppressed patients.

After graduating from the Barnard College at Columbia University with Cum Laude in Biochemistry, Dr. Ravitskiy was awarded Medical Doctorate degree by the New York University School of Medicine, NY.

She finished her Dermatology residency and served as Chief resident at the Robert Wood Johnson Medical School, NJ.

She was then selected to participate in the Advanced Clinical Dermatology fellowship at the Mayo Clinic, MN where she also completed a competitive Clinical Research Training Program.

Upon completion of these advanced degrees, Dr. Ravitskiy completed a rigorous one-year fellowship in Mohs micrographic surgery, cutaneous oncology, reconstructive surgery, and procedural dermatology under the nation’s premier cutanenous oncologists Drs. J. A. Zitelli and D. G. Brodland, Pittsburgh, PA.

After completing her training and prior to founding OSCI, Dr. Ravitskiy was the Assistant Professor and Director of Mohs and Dermatologic surgery at the Ohio State University.

Throughout her academic career, Dr. Ravitskiy was recognized with scholarships and awards. Most recently, she was nominated twice for a prestigious Tromovitch award by the American College of Mohs Surgery and served on the Women’s Health Task Force.

She has presented at national and international meetings on various dermatologic surgery topics, and has authored numerous book chapters and papers published in peer-reviewed scientific journals.

As a fellow of American Academy of Dermatology, American College of Mohs Surgery, and American Society for Dermatologic Surgery, Dr. Ravitskiy is committed to pursuing life-long continued medical education and dissemination of this knowledge to her peers.

Dr. Ravitskiy’s clinical expertise is in surgical treatment of cutaneous malignancies, including Merkel cell carcinoma, melanoma, dermatofibrosarcoma protuberans, and selected cases of angiosarcoma. She is proficient in reconstruction of facial and non-facial defects subsequent to cancer removal.

OSCI is dedicated to cutaneous oncology patients who require Mohs surgery and those with selected cancerous and benign lesions requiring surgical treatment. Dr. Ravitskiy’s research interests are in clinical trials and translational research involving the prevention of — as well as medical and surgical treatments of skin cancers.